|
|
Title | Creator | Date |
1 |
|
Papilledema in a Patient Being Treated for Multiple Sclerosis | Larry Frohman, MD; Roger E. Turbin, MD; Peter J. Wawrzusin, MD; Gaurav Srivastava, MD; Nicole M. Sakla, DO | 2021-12 |
2 |
|
Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis | Amy T. Waldman, MD, MSCE; Leslie Benson, MD; John R. Sollee, BS; Amy M. Lavery, PhD; Geraldine W. Liu, ALM; Ari J. Green, MD, MCR; Emmanuelle Waubant, MD; Gena Heidary, MD, PhD; Darrel Conger, CRA; Jennifer Graves, MD, PhD; Benjamin Greenberg, MD, MHS | 2021-12 |
3 |
|
Multiple Sclerosis: B Cells Take Center Stage | Anne-Katrin Pröbstel, MD; Stephen L. Hauser, MD | 2018-06 |
4 |
|
Multiple Sclerosis Therapy: Are We Ready for a One-Size-Fits-All Approach? | Bruce A. C. Cree, MD, PhD, MAS | 2018-06 |
5 |
|
Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies | Rachel C. Nolan, BA; Omar Akhand, BS; John-Ross Rizzo, MD, MSCI; Steven L. Galetta, MD; Laura J. Balcer, MD, MSCE | 2018-06 |
6 |
|
New Ways of 'Seeing' the Mechanistic Heterogeneity of Multiple Sclerosis Plaque Pathogenesis | Ethan I. Meltzer; Fiona E. Costello; Elliot M. Frohman; Teresa C. Frohman | 2018-03 |
7 |
|
Multiple Sclerosis: Eyes on the Future | Fiona E. Costello, MD, FRCPC; Jodie M. Burton, MD, MSc, FRCPC | 2018-03 |
8 |
|
Keep Your Eyes Wide Open: On Visual- and Vision-Related Measurements to Better Understand Multiple Sclerosis Pathophysiology | Yael Backner, Msc; Netta Levin, MD, PhD | 2018-03 |
9 |
|
Ocular Motor Manifestations of Multiple Sclerosis | Elodie Nerrant, MD; Caroline Tilikete, MD, PhD | 2017-09 |
10 |
|
Is Multiple Sclerosis Associated With a Lower Intraocular Pressure? | Norah S. Lincoff, MD; Andrea Buccilli, MD; Bianca Weinstock-Guttman, MD; Sandra Sieminski, MD; Sirin Gandhi, MD | 2017-09 |
11 |
|
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?: Comment | Prem S. Subramanian; Jiawei Zhao; Sarita B. Davé; Jiangxia Wang' | 2017-03 |
12 |
|
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?: Response. | Helena Felgueiras; Joana Parra; Simão Cruz; Pedro Pereira; Ana F. Santos; Adriana Rua; Dália Meira; Pedro Fonseca; Catarina Pedrosa; João N. Cardosa; Cristina Almeida; Maria Araújo; Ernestina Santos | 2017-03 |
13 |
|
Strabismus Surgery in Patients With Ocular Neuromyotonia: Potential Unmasking of the Condition and Effective Management Tool | J. Anna Kim, MD; Federico G. Velez, MD; Stacy L. Pineles, MD | 2016-09 |
14 |
|
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis | Silvana L. Costa, PhD; Óscar F. Gonçalves, PhD; Nancy D. Chiaravalloti, PhD; John DeLuca, PhD; Jorge Almeida, PhD | 2016-03 |